Evidence map›Paper›PMID 28284682›Full record

SynthesisVaccine2017

Childhood pneumococcal disease in Africa - A systematic review and meta-analysis of incidence, serotype distribution, and antimicrobial susceptibility.

Pui-Ying Iroh Tam, Beth K Thielen, Stephen K Obaro, Ann M Brearley, Alexander M Kaizer, Haitao Chu, Edward N Janoff

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Vaccine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. [The new 15-valent pneumococcal conjugate vaccine for the prevention ofJournal of preventive medicine and hygiene · 2023
    Article
  11. Observational
  12. Vaccines · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Pui-Ying Iroh TamUniversity of Minnesota Medical School, Minneapolis, MN, USA; Malawi-Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi. Electronic address: irohtam@mlw.mw.
Beth K ThielenUniversity of Minnesota Medical School, Minneapolis, MN, USA.
Stephen K ObaroUniversity of Nebraska Medical Center, Omaha, NE, USA.
Ann M BrearleyClinical Translational Science Institute, University of Minnesota, Minneapolis, MN, USA.
Alexander M KaizerClinical Translational Science Institute, University of Minnesota, Minneapolis, MN, USA.
Haitao ChuClinical Translational Science Institute, University of Minnesota, Minneapolis, MN, USA; Division of Biostatistics, University of Minnesota School of Public Health, Minneapolis, MN, USA.
Edward N JanoffUniversity of Colorado, Denver, CO, USA.

Funding

University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR000114 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R · 2012 to 2015
$35.0M
Mechanisms of Impaired HIV-associated B cell and Pneumococcal Vaccine responsesR01AI108479 · NIAID · UNIVERSITY OF COLORADO DENVER · PI JANOFF, EDWARD N · 2014 to 2018
$2.3M
Global Genomic and Proteomic Profiling of African Children with Typhoid FeverR01AI097493 · NIAID · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI OBARO, STEPHEN · 2012 to 2015
$1.6M
Statistical Methods and Software for Meta-analysis of Diagnostic TestsR03HS020666 · AHRQ · UNIVERSITY OF MINNESOTA · PI CHU, HAITAO · 2011 to 2012
$100k
AHRQ HHS R03 HS020666NCATS NIH HHS UL1 TR000114NIAID NIH HHS R01 AI097493NIAID NIH HHS R01 AI108479
6 · The paper itself

Abstract

backgroundDetermining the incidence, disease-associated serotypes and antimicrobial susceptibility of invasive pneumococcal disease (IPD) among children in Africa is essential in order to monitor the impact of these infections prior to widespread introduction of the pneumococcal conjugate vaccine (PCV).

methodsTo provide updated estimates of the incidence, serotype distribution, and antimicrobial susceptibility profile of Streptococcus pneumoniae causing disease in Africa, we performed a systematic review of articles published from 2000 to 2015 using Ovid Medline and Embase. We included prospective and surveillance studies that applied predefined diagnostic criteria. Meta-analysis for all pooled analyses was based on random-effects models.

resultsWe included 38 studies consisting of 386,880 participants in 21 countries over a total of 350,613 person-years. The pooled incidence of IPD was 62.6 (95% CI 16.9, 226.5) per 100,000 person-years, including meningitis which had a pooled incidence of 24.7 (95% CI 11.9, 51.6) per 100,000 person-years. The pooled prevalence of penicillin susceptibility was 78.1% (95% CI 61.9, 89.2). Cumulatively, PCV10 and PCV13 included 66.9% (95% CI 55.9, 76.7) and 80.6% (95% CI 66.3, 90.5) of IPD serotypes, respectively.

conclusionsOur study provides an integrated and robust summary of incidence data, serotype distribution and antimicrobial susceptibility for S. pneumoniae in children ≤5years of age in Africa prior to widespread introduction of PCV on the continent. The heterogeneity of studies and wide range of incidence rates across the continent indicate that surveillance efforts should be intensified in all regions of Africa to improve the integrity of epidemiologic data, vaccine impact and cost benefit. Although the incidence of IPD in young children in Africa is substantial, currently available conjugate vaccines are estimated to cover the majority of invasive disease-causing pneumococcal serotypes. These data provide a reliable baseline from which to monitor the impact of the broad introduction of PCV.

Indexed as

Penicillin ResistanceSerogroupAfricaHumansIncidencePneumococcal InfectionsPrevalenceStreptococcus pneumoniaeChildrenIncidenceInvasive pneumococcal diseaseMeta-analysisPenicillin susceptibilityPneumoniaSerotypeStreptococcus pneumoniaeSystematic review

Identifiers

PMID28284682
PMCPMC5404696

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.